| Transcript ID | Name | Length | RefSeq ID | Protein ID | Length | RefSeq ID | UniportKB ID |
|---|---|---|---|---|---|---|---|
| ENST00000559070 | RNF213-207 | 4644 | - | - | - (aa) | - | - |
| ENST00000572622 | RNF213-214 | 320 | - | - | - (aa) | - | - |
| ENST00000427003 | RNF213-203 | 3552 | - | - | - (aa) | - | - |
| ENST00000573919 | RNF213-217 | 899 | - | - | - (aa) | - | - |
| ENST00000571908 | RNF213-213 | 624 | - | - | - (aa) | - | - |
| ENST00000582970 | RNF213-220 | 21055 | XM_017024905 | ENSP00000464087 | 5207 (aa) | XP_016880394 | A0A0A0MTR7 |
| ENST00000574909 | RNF213-219 | 298 | - | - | - (aa) | - | - |
| ENST00000508628 | RNF213-204 | 17730 | XM_005257545 | ENSP00000425956 | 5256 (aa) | XP_005257602 | A0A0A0MTC1 |
| ENST00000560083 | RNF213-210 | 4212 | - | - | - (aa) | - | - |
| ENST00000560694 | RNF213-211 | 639 | - | - | - (aa) | - | - |
| ENST00000573548 | RNF213-216 | 616 | - | - | - (aa) | - | - |
| ENST00000411702 | RNF213-202 | 6428 | - | - | - (aa) | - | - |
| ENST00000574060 | RNF213-218 | 540 | - | - | - (aa) | - | - |
| ENST00000559603 | RNF213-208 | 765 | - | - | - (aa) | - | - |
| ENST00000570776 | RNF213-212 | 544 | - | - | - (aa) | - | - |
| ENST00000573038 | RNF213-215 | 699 | - | ENSP00000460462 | 106 (aa) | - | I3L3H9 |
| ENST00000559864 | RNF213-209 | 594 | - | - | - (aa) | - | - |
| ENST00000558116 | RNF213-205 | 3768 | - | - | - (aa) | - | - |
| ENST00000319921 | RNF213-201 | 5316 | - | ENSP00000324392 | 1063 (aa) | - | Q63HN8 |
| ENST00000558488 | RNF213-206 | 526 | - | - | - (aa) | - | - |
| ensgID | Trait | pValue | Pubmed ID |
|---|---|---|---|
| ENSG00000173821 | Platelet Function Tests | 2.6600000E-015 | - |
| ENSG00000173821 | Platelet Function Tests | 2.4400000E-015 | - |
| ENSG00000173821 | Moyamoya Disease | 2E-8 | 21048783 |
| ENSG00000173821 | 1-Alkyl-2-acetylglycerophosphocholine Esterase | 3E-6 | 23118302 |
| ENSG00000173821 | Migraine Disorders | 5E-10 | 27182965 |
| ENSG00000173821 | Migraine Disorders | 5E-10 | 27322543 |
| ensgID | SNP | Chromosome | Position | SNP-risk | Trait | PubmedID | 95% CI | Or or BEAT | EFO ID |
|---|---|---|---|---|---|---|---|---|---|
| ENSG00000173821 | rs17857135 | 17 | 80288362 | C | Migraine | 27322543 | [1.04-1.08] | 1.06 | EFO_0003821 |
| ENSG00000173821 | rs12051723 | 17 | 80350459 | T | Lipoprotein-associated phospholipase A2 activity change in response to statin therapy | 23118302 | [1.22-3.18] percent increase | 2.2 | EFO_0004746 |
| ENSG00000173821 | rs9916351 | 17 | 80265733 | A | Moyamoya disease | 29273593 | [NR] | 1.96 | Orphanet_2573 |
| ENSG00000173821 | rs11869363 | 17 | 80292960 | A | Moyamoya disease | 29273593 | [NR] | 1.7857143 | Orphanet_2573 |
| ENSG00000173821 | rs9907978 | 17 | 80327580 | A | Moyamoya disease | 29273593 | [NR] | 1.5873016 | Orphanet_2573 |
| ENSG00000173821 | rs10782008 | 17 | 80332071 | G | Moyamoya disease | 29273593 | [NR] | 2 | Orphanet_2573 |
| ENSG00000173821 | rs6565681 | 17 | 80374694 | A | Moyamoya disease | 21048783 | [2.73-8.49] | 4.82 | Orphanet_2573 |
| ENSG00000173821 | rs7220465 | 17 | 80286212 | ? | Migraine | 27182965 | [1.04-1.08] | 1.0582011 | EFO_0003821 |
| ENSG00000173821 | rs17857135 | 17 | 80288362 | T | Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL) | 28090653 | [1.03-1.59] | 1.2820514 | EFO_0004735|EFO_0007965|EFO_0000220 |

| Ensembl ID | Gene Symbol | Coverage | Identiy | Ortholog | Gene Symbol | Coverage | Identiy | Species |
|---|---|---|---|---|---|---|---|---|
| ENSG00000173821 | RNF213 | 100 | 66.495 | ENSMUSG00000070327 | Rnf213 | 100 | 72.930 | Mus_musculus |
| Go ID | Go_term | PubmedID | Evidence | Category |
|---|---|---|---|---|
| GO:0000209 | protein polyubiquitination | - | TAS | Process |
| GO:0001525 | angiogenesis | 26126547.26278786. | IMP | Process |
| GO:0002040 | sprouting angiogenesis | 21873635. | IBA | Process |
| GO:0002040 | sprouting angiogenesis | 26766444. | IMP | Process |
| GO:0004842 | ubiquitin-protein transferase activity | 21873635. | IBA | Function |
| GO:0004842 | ubiquitin-protein transferase activity | 21799892. | IDA | Function |
| GO:0004842 | ubiquitin-protein transferase activity | 26766444. | TAS | Function |
| GO:0005730 | nucleolus | 21873635. | IBA | Component |
| GO:0005730 | nucleolus | - | IDA | Component |
| GO:0005737 | cytoplasm | 21873635. | IBA | Component |
| GO:0005737 | cytoplasm | 21799892. | IDA | Component |
| GO:0005829 | cytosol | 21873635. | IBA | Component |
| GO:0005829 | cytosol | - | IDA | Component |
| GO:0005829 | cytosol | - | TAS | Component |
| GO:0006511 | ubiquitin-dependent protein catabolic process | 21873635. | IBA | Process |
| GO:0006511 | ubiquitin-dependent protein catabolic process | 26766444. | IMP | Process |
| GO:0016020 | membrane | 19946888. | HDA | Component |
| GO:0016567 | protein ubiquitination | 21799892. | IDA | Process |
| GO:0016887 | ATPase activity | 21799892.24658080.26126547. | IDA | Function |
| GO:0046872 | metal ion binding | - | IEA | Function |
| GO:0051260 | protein homooligomerization | 24658080.26126547. | IDA | Process |
| GO:0051865 | protein autoubiquitination | 21799892. | IDA | Process |
| GO:2000051 | negative regulation of non-canonical Wnt signaling pathway | 21873635. | IBA | Process |
| GO:2000051 | negative regulation of non-canonical Wnt signaling pathway | 26766444. | IMP | Process |